The research emerged from a larger 12-week randomized controlled trial designed to test whether high-intensity combined training could match traditional training in military-style fitness outcomes. Participants were young adults aged 18 to 27 from the Birmingham, Alabama area, all of whom were sedentary before enrollment. One group, labeled TRAD, performed 30 minutes of cycling at 70 percent of heart rate reserve followed by a full-body resistance routine of squats, presses, rows, and curls at three sets of 13 repetitions. The other group, called HITT, completed ten rounds of a maximal 30-second on/off circuit featuring box jumps, burpees, kettlebell swings, cycling and rowing sprints, battle ropes, and wall balls, then finished the same resistance exercises in superset form at lower volume and shorter rests. Both groups trained in the early morning after an overnight fast, and researchers drew blood before exercise, immediately after, three hours later, and again at 24 hours.

The analytical scale of the study is striking. Using untargeted metabolomics with both reverse-phase and HILIC chromatography in positive and negative ion modes, the team detected 10,793 serum compounds, annotated 5,215 of them, and consolidated these into 3,243 non-redundant features. After statistical filtering with a false discovery rate threshold of 0.10, 2,052 compounds changed significantly in at least one comparison, including 738 annotated endogenous metabolites spanning amino acids, lipids, acyl carnitines, nucleotides, and biogenic amines. Partial least squares-discriminant analysis showed that the serum metabolome clustered distinctly at the immediate and three-hour timepoints in both groups, before settling back toward baseline by 24 hours — a molecular signature of exertion that fades over roughly a day.

Within each group, the response was enormous. In the traditional group, 683 metabolites shifted below the significance threshold at one or more timepoints, compared with 585 in the high-intensity group. Immediately after exercise, both groups showed roughly equal numbers of rising and falling metabolites, but by three hours the picture skewed heavily toward accumulation: 333 upregulated metabolites in TRAD and 284 in HITT, dominated by fatty acids, conjugated fatty amines, and ketones. By 24 hours, the traditional group still had 183 altered metabolites while the high-intensity group had 86, indicating that the longer session left a deeper and more persistent biochemical footprint. The researchers attribute this to the sustained metabolic demand of continuous endurance work and the roughly doubled duration of the traditional prescription.

The timing of specific metabolite classes tells a coherent physiological story. Immediately after exercise, the blood was enriched for the active substrates of ATP generation — glucose, pyruvate, citrate, aconitate, and fumarate — along with products of purine catabolism such as hypoxanthine and uridine monophosphate. Working skeletal muscle, which cannot express xanthine oxidase, releases these purine intermediates into circulation, where the liver salvages them back into the ATP pool or converts them to uric acid. This salvage pathway is more energy-efficient than building nucleotides from scratch, and its appearance in the blood mirrors findings from earlier studies of moderate steady-state cycling and resistance exercise alone.

Three hours later, the emphasis shifted to recovery and fuel replenishment. Both groups showed elevated levels of 12,13-diHOME, an adipose-derived exerkine known to stimulate fatty acid uptake in skeletal muscle, alongside palmitoylcarnitine, which ferries fatty acid chains across the mitochondrial inner membrane for beta-oxidation, and a broad suite of long-chain fatty acids. Ninety-seven metabolites rose in both groups at this timepoint, most of them lipid-related, representing the largest shared signature in the study. The authors interpret this coordinated lipid mobilization as systemic replenishment of energy stores drained by the bout — the metabolic equivalent of refueling after a long drive.

Only a handful of metabolites distinguished the two training modes directly. Four met the false discovery threshold: capryloylglycine was lower in the traditional group immediately after exercise; hydroxynorleucine and acetylcholine were higher in that group at three hours; and D-mannose was lower in the traditional group at three hours. The acetylcholine finding is particularly intriguing because high-intensity exercise has previously been linked to reduced circulating choline and acetylcholine, yet choline itself fell in both groups here, suggesting that another mechanism — perhaps reduced acetyl-CoA availability or diminished choline acetyltransferase activity — drove the drop in the high-intensity group. The mannose difference may reflect the liver responding to glycolytic stress, since epinephrine-driven glycogenolysis releases mannose that cells can phosphorylate and channel into glycolysis or glycogen synthesis.

Some of the distinguishing metabolites remain biochemical mysteries. Capryloylglycine, a conjugate of the medium-chain fatty acid caprylic acid and glycine, has been described as a principal pancreatic metabolite in pigs and is elevated in the muscle of older adults, and genetic defects in mitochondrial beta-oxidation raise its levels — but why a traditional combined session would lower it acutely is unknown, since glycine availability was similar between groups. Hydroxynorleucine does not even appear as an identified entry in the Human Metabolome Database. The authors are candid that these findings need replication and mechanistic follow-up before any physiological meaning can be assigned.

Unbiased clustering across time revealed that most response patterns were shared between the two prescriptions, with key metabolites such as glucose, lactate, cortisol, palmitoylcarnitine, and glutathione rising or falling in parallel. Yet each mode also produced unique signatures: the traditional group showed a distinct cluster containing succinate that fell equally at both early timepoints, while the high-intensity group had a cluster with ornithine, glycine, and citrulline that dropped immediately and then climbed steadily through 24 hours. These idiosyncratic patterns, layered on top of the shared core response, are the clearest evidence yet that exercise dose and structure write distinguishable chemical signatures into the blood.

The study has caveats worth noting. Participants consumed a standardized protein drink after the immediate post-exercise blood draw to mimic real-world training, which could have contributed to some of the three-hour changes, though the lipid and amino acid patterns closely match those of fasted studies. All participants were untrained, so unaccustomed exertion itself likely drove much of the response, and the design covaried for sex rather than testing sex-specific effects, which the team has reported separately. Still, as the first timecourse study of the acute circulating metabolomic response to combined endurance and resistance exercise, the work establishes that a 45-minute high-intensity session and a 90-minute traditional session converge on the same fundamental biology — fuel burning, purine salvage, lipid mobilization — while leaving behind subtly different molecular fingerprints. For time-pressed exercisers and military planners alike, that suggests the shorter workout may deliver much of the same metabolic conversation, just in a more compressed dialect.

Subject of Research: Acute serum metabolomic responses to traditional versus high-intensity combined endurance and resistance exercise in young adults

Article Title: Serum metabolomics signatures after an acute bout of combined traditional or high‐intensity tactical training in young adults

Article References: Graham, Z. A., Pathak, K. V., Garcia‐Mansfield, K., Lavin, K. M., Torres, A. R., McAdam, J. S., Broderick, T., Pirrotte, P., & Bamman, M. M. (2026). Serum metabolomics signatures after an acute bout of combined traditional or high‐intensity tactical training in young adults. Physiological Reports, 14(18), Article e71094. https://doi.org/10.14814/phy2.71094

Image Credits: AI Generated

DOI: 10.14814/phy2.71094

Keywords: metabolomics, exercise physiology, high-intensity interval training, resistance training, serum metabolites, combined exercise, fatty acid oxidation, purine salvage, recovery, military fitness, young adults, Physiological Reports

PSCI is a notoriously difficult target. Its clinical course is heterogeneous, ranging from subtle deficits in attention and executive function to overt dementia, and its trajectory is highly variable from patient to patient. Current prediction relies largely on conventional clinical variables, neuroimaging findings, and bedside cognitive screening instruments, all of which have well-documented weaknesses during the acute phase. Aphasia, sedation, and neurological fluctuation routinely interfere with early cognitive assessment, while existing clinical prediction models built on variables such as NIHSS score, age, diabetes, atrial fibrillation, and homocysteine, though reported to achieve AUCs between 0.77 and 0.90 in development cohorts, still fail to capture the complex pathophysiology underlying cognitive decline. What clinicians lack is an objective, quantifiable biomarker panel that can stratify risk before symptoms emerge.

The logic behind a metabolic approach is compelling. Ischemic stroke triggers a cascade of disrupted energy metabolism, mitochondrial dysfunction, excitotoxicity, oxidative stress, and neuroinflammation, many aspects of which leave fingerprints in circulating metabolite levels. Stroke also provokes broad peripheral changes, including lipid remodeling, amino acid dysregulation, and perturbation of neurotransmitter-related pathways, which can shape cognitive recovery by affecting neuronal integrity, synaptic plasticity, and cerebrovascular health. Previous work has hinted at the potential: elevated serum ratios of quinolinic acid to kynurenic acid have predicted three-month cognitive outcomes, and the Nor-COAST cohort linked neopterin, kynurenine metabolites, and vitamin B6-related indicators to PSCI development. Choline pathway metabolites and homocysteine have also been independently associated with post-stroke cognitive risk. But most of these studies were targeted, focused on one or a few pathways, and rarely extended to building validated prediction models in the acute window.

The new study, led by Xiangwen Hao and Bianying Feng of Shanghai Fourth People’s Hospital with senior authors Li Tian and Qiu Hong Man, took an untargeted approach. The team enrolled 156 patients admitted within twenty-four hours of symptom onset and, after exclusions for pre-existing cognitive impairment, severe aphasia, psychiatric illness, and other factors, assembled a final cohort of 130. Serum collected on admission was subjected to untargeted liquid chromatography-tandem mass spectrometry using both reversed-phase and HILIC separation on a high-resolution Orbitrap platform, with pooled quality-control samples inserted after every ten study samples to monitor instrument stability. After rigorous preprocessing, including variance-stabilizing normalization and random-forest-based batch correction, 806 serum metabolite features were retained for analysis.

Three months later, patients were assessed with the Telephone Montreal Cognitive Assessment, a validated remote screening tool, and classified as PSCI if they scored below the pre-specified cutoff of 19. The cohort split almost evenly: 64 patients developed cognitive impairment and 66 remained cognitively intact. Comparison of the two groups’ admission serum profiles revealed 51 candidate differential metabolites, twenty upregulated and thirty-one downregulated in those who later declined cognitively. The largest fold change belonged to 5-aminopentanoic acid, a lysine degradation intermediate produced both endogenously and by gut bacteria, which was elevated in PSCI patients and negatively correlated with cognitive scores. Strikingly, key intermediates of caffeine catabolism, including 1,3-dimethyluric acid, theophylline, and 3,7-dimethyluric acid, were markedly reduced in the PSCI group, suggesting altered purine metabolism and potentially disrupted adenosine receptor signaling, a pathway implicated in neuronal excitability, neuroinflammation, and synaptic regulation.

Pathway enrichment analysis mapped these differences onto several interconnected metabolic domains rather than a single dominant mechanism. Bile acid metabolites such as taurocholic acid, cholic acid, and glycochenodeoxycholic acid pointed to bile acid biosynthesis and secretion pathways, increasingly recognized as players in gut-liver-brain communication and systemic inflammation. Lipid features, including docosahexaenoic acid, linoleic acid, and multiple glycerophospholipid species, mapped to unsaturated fatty acid and glycerophospholipid metabolism, and correlated positively with cognitive scores, consistent with the known importance of polyunsaturated fatty acids in membrane structure and synaptic function. Amino acid-related pathways, including arginine and proline metabolism, rounded out the picture. Notably, docosahexaenoic acid and two ether-linked phospholipid species correlated positively with three-month cognitive scores, while the purine metabolite 7-methylguanosine and the indole compound indole-4-carboxaldehyde correlated negatively, tying purine, tryptophan-derived, and lipid metabolic signals directly to cognitive performance.

To move beyond single metabolites, the researchers applied multiscale embedded correlation network analysis across all 806 metabolites spanning thirty biochemical categories. The result was striking: 15,120 metabolite pairs showed significantly different correlation patterns between the two groups. Nearly half of these involved outright reversals, with 3,807 pairs flipping from positive correlations in cognitively intact patients to negative correlations in PSCI patients and 3,671 showing the reverse transition. Others involved newly forged strong correlations or the dissolution of existing ones. The magnitude of this correlation rewiring suggests that patients who later developed cognitive impairment experienced a fundamentally reorganized acute-phase metabolic network, encompassing amino acid handling, lipid metabolism, inflammatory responses, and microbiota-associated features, rather than isolated changes in individual compounds.

The centerpiece of the study is its prediction model. Using bootstrap-LASSO stability selection across 1,000 iterations, with a selection-frequency threshold of 75 percent chosen through sensitivity analysis, the team retained six metabolites: 6-hydroxymellein, 21-deoxycortisol, inosine, 2-hydroxy-3-methylbutyric acid, isoleucyl-arginine, and propylparaben. Under stratified ten-fold cross-validation, this metabolite-only model achieved an AUC of 0.774, with a sensitivity of 0.609 and a specificity of 0.848 at the optimal cutoff. Within the multivariable model, 21-deoxycortisol, an intermediate of adrenal corticosteroid synthesis, showed the strongest positive association with PSCI risk, with an odds ratio of 2.15, hinting at a role for acute hypothalamic-pituitary-adrenal axis activation, a stress response long linked to hippocampal vulnerability and impaired synaptic plasticity. Elevated inosine and the branched-chain amino acid catabolic intermediate 2-hydroxy-3-methylbutyric acid also carried increased odds of impairment, while the dipeptide isoleucyl-arginine and the preservative-derived propylparaben trended toward protective associations.

Perhaps the most provocative result is what the comparison models revealed. A core clinical-only model built from age, sex, education, admission NIHSS score, body mass index, and prior stroke history managed an AUC of just 0.525, barely better than chance in this cohort. Adding the clinical variables to the metabolites did not help either; the combined model reached an AUC of 0.685, still short of the metabolite-only panel. Calibration analysis showed good agreement between predicted and observed risk, with no significant lack of fit, and decision curve analysis indicated the model would deliver net benefit over both treat-all and treat-none strategies across a broad range of threshold probabilities. The authors note that the six predictors span endogenous steroidogenic, purinergic, and amino acid catabolic pathways alongside dietary and xenobiotic exposure markers, underscoring that the acute metabolic risk signature is multidimensional.

The researchers are careful to frame their findings as an early step rather than a finished clinical tool. The cognitive outcome was assessed by telephone screening rather than a full neuropsychological battery, and the model was validated only internally, without an independent external cohort. Untargeted mass spectrometry features would also need conversion into targeted, reproducible, and clinically feasible assays before any bedside deployment. Still, the study demonstrates that the blood of a newly admitted stroke patient already contains readable information about how the brain will fare over the following months. If external validation confirms the six-metabolite panel, emergency departments could one day use a routine admission blood draw to flag high-risk patients for closer cognitive follow-up and early preventive intervention, turning the first hours after a stroke into a window of opportunity for protecting the mind as well as saving it.

Subject of Research: Acute-phase serum metabolomic signatures for early prediction of post-stroke cognitive impairment after ischemic stroke

Article Title: Acute-phase serum metabolomics signatures for predicting post-stroke cognitive impairment after ischemic stroke: a prospective cohort study

Article References: Acute-phase serum metabolomics signatures for predicting post-stroke cognitive impairment after ischemic stroke: a prospective cohort study. (n.d.). https://doi.org/10.1007/s11306-026-02521-6

Image Credits: AI Generated

DOI: 10.1007/s11306-026-02521-6

Keywords: post-stroke cognitive impairment, ischemic stroke, metabolomics, biomarkers, serum metabolites, LC-MS/MS, prediction model, bile acid metabolism, caffeine metabolism, docosahexaenoic acid, Bootstrap-LASSO, risk stratification